28 | Kynurenic Acid (Kynurenate)IBA
01/2021
-
08/2003 |
27 | KynurenineIBA
01/2021
-
01/2006 |
19 | Tryptophan (L-Tryptophan)FDA Link
01/2021
-
03/2008 |
9 | Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA
01/2019
-
07/2005 |
8 | Quinolinic AcidIBA
01/2020
-
01/2003 |
8 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2017
-
01/2006 |
6 | EnzymesIBA
01/2019
-
12/2008 |
6 | polyglutamineIBA
04/2012
-
01/2003 |
5 | 3-hydroxykynurenineIBA
11/2017
-
01/2003 |
5 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2016
-
08/2003 |
4 | Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2017
-
08/2003 |
4 | N-Methylaspartate (NMDA)IBA
03/2010
-
08/2003 |
3 | Acetylcholine (Acetylcholine Chloride)FDA Link
11/2017
-
11/2011 |
3 | Huntingtin ProteinIBA
04/2012
-
12/2004 |
3 | Proteins (Proteins, Gene)FDA Link
02/2010
-
01/2003 |
2 | Dronabinol (THC)FDA LinkGeneric
01/2020
-
11/2013 |
2 | kynurenine-oxoglutarate transaminaseIBA
01/2019
-
03/2014 |
2 | ProdrugsIBA
01/2019
-
09/2002 |
2 | CytokinesIBA
01/2018
-
10/2016 |
2 | Serotonin (5 Hydroxytryptamine)IBA
01/2017
-
08/2015 |
2 | Biomarkers (Surrogate Marker)IBA
08/2015
-
07/2014 |
2 | Neurotransmitter Agents (Neurotransmitter)IBA
07/2014
-
08/2010 |
2 | Ro 61-8048IBA
11/2013
-
07/2005 |
2 | Pharmaceutical PreparationsIBA
11/2013
-
07/2007 |
2 | NeurotoxinsIBA
02/2012
-
07/2006 |
2 | alpha7 Nicotinic Acetylcholine ReceptorIBA
03/2010
-
04/2005 |
2 | Levodopa (L Dopa)FDA LinkGeneric
01/2008
-
07/2005 |
1 | RestylaneIBA
04/2022 |
1 | Adenosine (Adenocard)FDA LinkGeneric
01/2021 |
1 | Neuroprotective AgentsIBA
01/2020 |
1 | PlasticsIBA
01/2020 |
1 | EndocannabinoidsIBA
05/2019 |
1 | Poly I-CIBA
01/2019 |
1 | BFF-816IBA
01/2019 |
1 | Essential Amino AcidsIBA
01/2018 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2018 |
1 | Formaldehyde (Formol)FDA Link
10/2017 |
1 | CarrageenanIBA
10/2017 |
1 | Gabapentin (Neurontin)FDA LinkGeneric
10/2017 |
1 | Dizocilpine Maleate (Dizocilpine)IBA
10/2017 |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2016 |
1 | Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA
11/2016 |
1 | InterferonsIBA
10/2016 |
1 | KetamineFDA LinkGeneric
10/2015 |
1 | gamma-Aminobutyric Acid (GABA)IBA
07/2014 |
1 | Enzyme Inhibitors (Inhibitors, Enzyme)IBA
03/2014 |
1 | CannabinoidsIBA
11/2013 |
1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
11/2013 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
11/2012 |
1 | Antipsychotic Agents (Antipsychotics)IBA
04/2012 |
1 | IronIBA
02/2012 |
1 | Messenger RNA (mRNA)IBA
07/2011 |
1 | Cholinergic Agents (Cholinergics)IBA
01/2010 |
1 | Transaminases (Aminotransferases)IBA
12/2008 |
1 | IsoenzymesIBA
12/2008 |
1 | Histone Deacetylase InhibitorsIBA
03/2008 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
03/2008 |
1 | SilverIBA
01/2008 |
1 | LigandsIBA
07/2007 |
1 | Galantamine (Galanthamine)FDA LinkGeneric
07/2007 |